Shintaro Yagi1, Toshimi Kaido2, Taku Iida2, Atsushi Yoshizawa2, Hideaki Okajima2, Shinji Uemoto2. 1. Department of Hepatobiliary, Pancreas and Transplant Surgery, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. shintaro@kuhp.kyoto-u.ac.jp. 2. Department of Hepatobiliary, Pancreas and Transplant Surgery, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
Abstract
BACKGROUND AND PURPOSE: It is now known that post-transplant graft function after deceased-donor liver transplantation and living-donor liver transplantation (LDLT) differ; however, there is no report assessing the relationship between graft function and the development of new-onset diabetes mellitus after transplantation (NODAT). We conducted this study to identify the predictive risk factors for NODAT, including graft function after LDLT. METHODS: The subjects of this study were 175 adult recipients who underwent LDLT at Kyoto University Hospital between 2006 and 2010, and survived for more than 3 months (median observation period, 1046 days). RESULTS: The 1-, 2-, and 3-year incidences of NODAT after LDLT were 26.1, 32.0, and 33.4%, respectively. Pre-transplant diabetes was associated with poor survival (p = 0.0048), whereas NODAT was not associated with patient survival. In the multivariate analysis, recipient age ≥40, a tacrolimus trough level ≥8 ng/mL 3 months after LDLT, and cholinesterase (ChE) <185 IU/L 3 months after LDLT were the independent risk factors for NODAT. CONCLUSIONS: Poor graft synthetic function 3 months after LDLT as well as older age of the recipient and a higher tacrolimus concentration were strongly associated with NODAT development after LDLT.
BACKGROUND AND PURPOSE: It is now known that post-transplant graft function after deceased-donor liver transplantation and living-donor liver transplantation (LDLT) differ; however, there is no report assessing the relationship between graft function and the development of new-onset diabetes mellitus after transplantation (NODAT). We conducted this study to identify the predictive risk factors for NODAT, including graft function after LDLT. METHODS: The subjects of this study were 175 adult recipients who underwent LDLT at Kyoto University Hospital between 2006 and 2010, and survived for more than 3 months (median observation period, 1046 days). RESULTS: The 1-, 2-, and 3-year incidences of NODAT after LDLT were 26.1, 32.0, and 33.4%, respectively. Pre-transplant diabetes was associated with poor survival (p = 0.0048), whereas NODAT was not associated with patient survival. In the multivariate analysis, recipient age ≥40, a tacrolimus trough level ≥8 ng/mL 3 months after LDLT, and cholinesterase (ChE) <185 IU/L 3 months after LDLT were the independent risk factors for NODAT. CONCLUSIONS: Poor graft synthetic function 3 months after LDLT as well as older age of the recipient and a higher tacrolimus concentration were strongly associated with NODAT development after LDLT.
Authors: G Perseghin; V Mazzaferro; L P Sereni; E Regalia; S Benedini; E Bazzigaluppi; A Pulvirenti; A A Leão; G Calori; R Romito; D Baratti; L Luzi Journal: Hepatology Date: 2000-03 Impact factor: 17.425
Authors: Steven Van Laecke; Federico Desideri; Anja Geerts; Hans Van Vlierberghe; Frederik Berrevoet; Xavier Rogiers; Roberto Troisi; Bernard de Hemptinne; Raymond Vanholder; Isabelle Colle Journal: Liver Transpl Date: 2010-11 Impact factor: 5.799
Authors: Jang I Moon; Ralph Barbeito; Raquel N Faradji; Jeffrey J Gaynor; Andreas G Tzakis Journal: Transplantation Date: 2006-12-27 Impact factor: 4.939
Authors: K Tanaka; S Uemoto; Y Tokunaga; S Fujita; K Sano; T Nishizawa; H Sawada; I Shirahase; H J Kim; Y Yamaoka Journal: Ann Surg Date: 1993-01 Impact factor: 12.969
Authors: Anitha D Yadav; Yu-Hui Chang; Bashar A Aqel; Thomas J Byrne; Harini A Chakkera; David D Douglas; David C Mulligan; Jorge Rakela; Hugo E Vargas; Elizabeth J Carey Journal: J Transplant Date: 2013-09-24
Authors: Jong Man Kim; Shin Hwang; Kwang-Woong Lee; Jae-Geun Lee; Je Ho Ryu; Bong-Wan Kim; Dong Lak Choi; Young Kyoung You; Dong-Sik Kim; Yang Won Nah; Koo Jeong Kang; Jai Young Cho; Geun Hong; In Seok Choi; Hee Chul Yu; Dongho Choi; Myoung Soo Kim Journal: Hepatobiliary Surg Nutr Date: 2020-08 Impact factor: 7.293
Authors: Maria J Peláez-Jaramillo; Allison A Cárdenas-Mojica; Paula V Gaete; Carlos O Mendivil Journal: Diabetes Ther Date: 2018-02-06 Impact factor: 2.945
Authors: Yip Han Chin; Hon Qin Marcus Tan; Cheng Han Ng; Darren Jun Hao Tan; Snow Yunni Lin; Daniel Q Huang; Chin Meng Khoo; Mark Dhinesh Muthiah Journal: J Clin Med Date: 2021-03-03 Impact factor: 4.241